Patents Assigned to ANTECIP BIOVENTURES II LLC
  • Compositions and methods comprising erythrohydroxybupropion and related compounds for improving the efficacy of dextromethorphan
    Patent number: 9205083
    Abstract: This disclosure relates to methods of improving the efficacy of dextromethorphan, or providing beneficial pharmacokinetic effects to dextromethorphan, comprising co-administering erythrohydroxybupropion, or a prodrug thereof, and dextromethorphan to a human being. Dosage forms, drug delivery systems, and methods related to dextromethorphan and erythrohydroxybupropion or a prodrug of erythrohydroxybupropion are also disclosed.
    Type: Grant
    Filed: November 26, 2014
    Date of Patent: December 8, 2015
    Assignee: ANTECIP BIOVENTURES II LLC
    Inventor: Herriot Tabuteau
  • Compositions comprising RANK/RANKL antagonists and related compounds for treating pain
    Patent number: 9205045
    Abstract: Disclosed herein are methods of treating pain using comprising RANK/RANKL antagonists.
    Type: Grant
    Filed: July 29, 2015
    Date of Patent: December 8, 2015
    Assignee: ANTECIP BIOVENTURES II LLC
    Inventor: Herriot Tabuteau
  • Compositions and methods for reducing dextrorphan plasma levels and related pharmacodynamic effects
    Patent number: 9198905
    Abstract: This disclosure relates to methods of decreasing dextrorphan plasma levels comprising co-administering hydroxybupropion, or a prodrug thereof, and dextromethorphan to a human being in need of treatment with dextromethorphan. Dosage forms, drug delivery systems, and methods related to dextromethorphan and hydroxybupropion or a prodrug of bupropion are also disclosed.
    Type: Grant
    Filed: November 21, 2014
    Date of Patent: December 1, 2015
    Assignee: ANTECIP BIOVENTURES II LLC
    Inventor: Herriot Tabuteau
  • Bupropion as a modulator of drug activity
    Patent number: 9168234
    Abstract: This disclosure relates to methods administering bupropion or a prodrug thereof in conjunction with dextromethorphan to a human being. Dosage forms, drug delivery systems, and methods related to dextromethorphan or dextrorphan and bupropion or a prodrug of bupropion are also disclosed.
    Type: Grant
    Filed: January 23, 2015
    Date of Patent: October 27, 2015
    Assignee: ANTECIP BIOVENTURES II LLC
    Inventor: Herriot Tabuteau
  • Compositions for oral adminstration of zoledronic acid or related compounds for treating Paget's disease of bone
    Patent number: 9149487
    Abstract: Oral dosage forms of bisphosphonate compounds, such as zoledronic acid, can be used to treat or alleviate pain or related conditions. The oral bioavailability of zoledronic acid can be enhanced by administering the zoledronic acid in the disodium salt form.
    Type: Grant
    Filed: May 15, 2014
    Date of Patent: October 6, 2015
    Assignee: ANTECIP BIOVENTURES II LLC
    Inventor: Herriot Tabuteau
  • Substituted imidazolium compounds for treating disease
    Patent number: 9079927
    Abstract: The present disclosure relates to therapeutic compositions comprising substituted imidazoliums having multiple acidic groups. The compounds may be used to treat diseases or conditions such as those associated with bone, cancer, or pain. Compositions, dosage forms, methods of treating diseases or conditions, methods of preparation, and other related embodiments related to the substituted imidazoliums are also described herein.
    Type: Grant
    Filed: January 29, 2015
    Date of Patent: July 14, 2015
    Assignee: ANTECIP BIOVENTURES II LLC
    Inventors: Herriot Tabuteau, Eric K. H. Dinkla
  • Compositions for oral administration of zoledronic acid or related compounds for treating low back pain
    Patent number: 9034889
    Abstract: Oral dosage forms of bisphosphonate compounds, such as zoledronic acid, can be used to treat or alleviate pain or related conditions. The oral bioavailabilty of zoledronic acid can be enhanced by administering the zoledronic acid in the disodium salt form.
    Type: Grant
    Filed: May 15, 2014
    Date of Patent: May 19, 2015
    Assignee: ANTECIP BIOVENTURES II LLC
    Inventor: Herriot Tabuteau
  • Substituted imidazolium compounds for treating disease
    Patent number: 9006279
    Abstract: The present disclosure relates to therapeutic compositions comprising substituted imidazoliums having multiple acidic groups. The compounds may be used to treat diseases or conditions such as those associated with bone, cancer, or pain. Compositions, dosage forms, methods of treating diseases or conditions, methods of preparation, and other related embodiments related to the substituted imidazoliums are also described herein.
    Type: Grant
    Filed: July 29, 2014
    Date of Patent: April 14, 2015
    Assignee: Antecip Bioventures II LLC
    Inventor: Herriot Tabuteau
  • Therapeutic compositions comprising imidazole and imidazolium compounds
    Patent number: 8962599
    Abstract: Therapeutic compositions comprising substituted imidazole or imidazolium compounds may be used for a number of medical purposes, such as treatment of undesirable conditions or diseases, including disease or conditions related to bone, cancer, and/or pain.
    Type: Grant
    Filed: September 9, 2014
    Date of Patent: February 24, 2015
    Assignee: Antecip Bioventures II LLC
    Inventor: Herriot Tabuteau
  • Substituted imidazolium compounds for treating disease
    Patent number: 8901162
    Abstract: The present disclosure relates to therapeutic compositions comprising substituted imidazoliums having multiple acidic groups. The compounds may be used to treat diseases or conditions such as those associated with bone, cancer, or pain. Compositions, dosage forms, methods of treating diseases or conditions, methods of preparation, and other related embodiments related to the substituted imidazoliums are also described herein.
    Type: Grant
    Filed: May 28, 2014
    Date of Patent: December 2, 2014
    Assignee: Antecip Bioventures II LLC
    Inventor: Herriot Tabuteau
  • Therapeutic compositions comprising imidazole and imidazolium compounds
    Patent number: 8901161
    Abstract: Therapeutic compositions comprising at least two substituted imidazole or imidazolium compounds may be used for a number of medical purposes, such as treatment of undesirable conditions or diseases, including disease or conditions related to bone, cancer, and/or pain.
    Type: Grant
    Filed: May 27, 2014
    Date of Patent: December 2, 2014
    Assignee: Antecip Bioventures II LLC
    Inventor: Herriot Tabuteau
  • Substituted imidazolium compounds for treating disease
    Patent number: 8835650
    Abstract: The present disclosure relates to therapeutic compositions comprising substituted imidazoliums having multiple acidic groups. The compounds may be used to treat diseases or conditions such as those associated with bone, cancer, or pain. Compositions, dosage forms, methods of treating diseases or conditions, methods of preparation, and other related embodiments related to the substituted imidazoliums are also described herein.
    Type: Grant
    Filed: May 28, 2014
    Date of Patent: September 16, 2014
    Assignee: Antecip Bioventures II LLC
    Inventor: Herriot Tabuteau
  • TREATING DISEASE USING COMPOSITIONS FOR ORAL ADMINISTRATION OF ZOLEDRONIC ACID OR RELATED COMPOUNDS
    Publication number: 20140256683
    Abstract: Oral dosage forms of bisphosphonate compounds, such as zoledronic acid, can be used to treat or alleviate pain or related conditions.
    Type: Application
    Filed: May 15, 2014
    Publication date: September 11, 2014
    Applicant: Antecip Bioventures II LLC
    Inventor: Herriot Tabuteau
  • COMPOSITIONS FOR ORAL ADMINSTRATION OF ZOLEDRONIC ACID OR RELATED COMPOUNDS FOR TREATING PAGET'S DISEASE OF BONE
    Publication number: 20140249113
    Abstract: Oral dosage forms of bisphosphonate compounds, such as zoledronic acid, can be used to treat or alleviate pain or related conditions.
    Type: Application
    Filed: May 15, 2014
    Publication date: September 4, 2014
    Applicant: Antecip Bioventures II LLC
    Inventor: Herriot Tabuteau
  • COMPOSITIONS FOR ORAL ADMINISTRATION OF ZOLEDRONIC ACID OR RELATED COMPOUNDS FOR TREATING LOW BACK PAIN
    Publication number: 20140249112
    Abstract: Oral dosage forms of bisphosphonate compounds, such as zoledronic acid, can be used to treat or alleviate pain or related conditions.
    Type: Application
    Filed: May 15, 2014
    Publication date: September 4, 2014
    Applicant: Antecip Bioventures II LLC
    Inventor: Herriot Tabuteau
  • TREATMENT OF ARTHRITIS USING DOSAGE FORMS FOR ORAL ADMINISTRATION OF ZOLEDRONIC ACID OR RELATED COMPOUNDS
    Publication number: 20140249110
    Abstract: Oral dosage forms of bisphosphonate compounds, such as zoledronic acid, can be used to treat or alleviate pain or related conditions.
    Type: Application
    Filed: May 15, 2014
    Publication date: September 4, 2014
    Applicant: Antecip Bioventures II LLC
    Inventor: Herriot Tabuteau
  • COMPOSITIONS FOR ORAL ADMINISTRATION OF ZOLEDRONIC ACID OR RELATED COMPOUNDS FOR TREATING ANKYLOSING SPONDYLITIS
    Publication number: 20140249109
    Abstract: Oral dosage forms of bisphosphonate compounds, such as zoledronic acid, can be used to treat or alleviate pain or related conditions.
    Type: Application
    Filed: May 15, 2014
    Publication date: September 4, 2014
    Applicant: Antecip Bioventures II LLC
    Inventor: Herriot Tabuteau
  • COMPOSITIONS FOR ORAL ADMINISTRATION OF ZOLEDRONIC ACID OR RELATED COMPOUNDS FOR TREATING MULTIPLE MYELOMA
    Publication number: 20140249111
    Abstract: Oral dosage forms of bisphosphonate compounds, such as zoledronic acid, can be used to treat or alleviate pain or related conditions.
    Type: Application
    Filed: May 15, 2014
    Publication date: September 4, 2014
    Applicant: Antecip Bioventures II LLC
    Inventor: Herriot Tabuteau
  • COMPOSITIONS FOR ORAL ADMINISTRATION OF ZOLEDRONIC ACID OR RELATED COMPOUNDS FOR TREATING DISEASE
    Publication number: 20140249317
    Abstract: Oral dosage forms of bisphosphonate compounds, such as zoledronic acid, can be used to treat or alleviate pain or related conditions.
    Type: Application
    Filed: May 15, 2014
    Publication date: September 4, 2014
    Applicant: Antecip Bioventures II LLC
    Inventor: Herriot Tabuteau
  • DOSAGE FORMS FOR ORAL ADMINISTRATION OF ZOLEDRONIC ACID OR RELATED COMPOUNDS FOR TREATING DISEASE
    Publication number: 20140249107
    Abstract: Oral dosage forms of bisphosphonate compounds, such as zoledronic acid, can be used to treat or alleviate pain or related conditions.
    Type: Application
    Filed: May 15, 2014
    Publication date: September 4, 2014
    Applicant: Antecip Bioventures II LLC
    Inventor: Herriot Tabuteau